Decline in serum total cholesterol and the risk of death from cancer

Epidemiology

Volumn 8, Issue 2, 1997, Pages 137-143

  Zureik, Mahmoud ^a   Courbon, Dominique ^a   Ducimetière, Pierre ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

cancer mortality; cohort study; repeat measurements; serum cholesterol; serum cholesterol change

Indexed keywords

CHOLESTEROL;

ADULT; ARTICLE; CANCER MORTALITY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0031050517     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-199703000-00003     Document Type: Article

References (67)

1. Cambien F, Ducimetière P, Richard JL. Total serum cholesterol and cancer mortality in a middle-aged male population. Am J Epidemiol 1980;112:388-394.
2. Nydegger UE, Bulter RE. Serum lipoprotein level in patients with cancer. Cancer Res 1972;32:1756-1760.
3. Rose G, Blackburn H, Key A, Kannel WB, Paul O, Reid DD, Stamler J. Colon cancer and blood cholesterol. Lancet 1974;1:181-183.
4. Kark JD, Smith AH, Hames CG. The relationship of serum cholesterol to the incidence of cancer in Evans County, Georgia. J Chron Dis 1979;33: 311-322.
5. Feinleib M. On a possible inverse relationship between serum cholesterol and cancer mortality. Am J Epidemiol 1981;114:5-10.
6. Kagan A, McGee DL, Yano K, Rhoads GO, Nomura A. Serum cholesterol and mortality in a Japanese-American population: the Honolulu Heart Program. Am J Epidemiol 1981;114:11-20.
7. Kozarevic DJ, McGee D, Vojvodic N, Gordon T, Racic Z, Zukel W, Dawber T. Serum cholesterol and mortality: the Yugoslavia Cardiovascular Disease Study. Am J Epidemiol 1981;114:21-28.
8. García-Palmieri MR, Sorlie PD, Costas RJ, Havlik RJ. An apparent inverse relationship between serum cholesterol and cancer mortality in Puerto Rico. Am J Epidemiol 1981;114:29-40.
9. International Collaborative Group. Circulating cholesterol level and risk of death from cancer in men aged 40 to 69 years: experience of an International Collaborative Group. JAMA 1982;248:2853-2859.
10. Sorlie PD, Feinleib M. The serum cholesterol-cancer relationship: an analysis of time trends in the Framingham Study. J Natl Cancer Inst 1982;69: 989-996.
11. Morris DL, Borhani NO, Fitzsimons E, Hardy RJ, Hawkins CM, Kraus JF, La Barthe DR, Mastbaum L, Payne GH. Serum cholesterol and cancer in the Hypertension Detection and Follow-up Program. Cancer 1983;52:1754-1759.
12. Keys A, Aravanis C, Blackburn H, Buzina R, Dontas AS, Fidanza F, Karvonen MJ, Menotti A, Nedeljkovic S, Punsar S, Toshima H. Serum cholesterol and cancer mortality in the Seven Countries Study. Am J Epidemiol 1985;121:870-883.
13. Salmond CE, Beaglehole R, Prior IAM. Are low cholesterol values associated with excess mortality? BMJ 1985;290:422-424.
14. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987;257:2176-2180.
15. Sherwin RW, Wentworth DN, Cutler JA, Hulley SB, Kuller LH, Stamler J. Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial. JAMA 1987;257:943-948.
16. Schatzkin AG, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Albanes D, Larson DB, Licitra LM. Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res 1988;48:452-458.
17. Knekt P, Reunanen A, Aromaa A, Heliovaara M, Hakulinen T, Hakama M. Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol 1988;41:519-530.
18. Tornberg SA, Holm LE, Carstensen JM, Eklund GA. Cancer incidence and cancer mortality in relation to serum cholesterol. J Natl Cancer Inst 1989; 81:1917-1921.
19. Isles CG, Hole DJ, Gillis CR, Hawthorne VM, Lever AF. Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey. BMJ 1989;298:920-924.
20. Cowan LD, O'Connell DL, Criqui MH, Barrett-Connor E, Bush TL, Wallace RB. Cancer mortality and lipid and protein levels: the lipid research clinics program mortality follow-up study. Am J Epidemiol 1990;131:468-482.
21. Stemmermann GN, Chyou PH, Kagan A, Nomura AM, Yano K. Serum cholesterol and mortality among Japanese-American men: the Honolulu (Hawaii) Heart Program. Arch Intern Med 1991;151:969-972.
22. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, Shih J, Stamler J, Wentworth D. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 1992;152:1490-1500.
23. Harris T, Feldman JJ, Kleinman JC, Ettinger WHJ, Makuc DM, Schatzkin AG. The low cholesterol-mortality association in a national cohort. J Clin Epidemiol 1992;45:595-601.
24. Schuit AJ, van Dijk CEMJ, Dekker JM, Schouten EG, Kok FJ. Inverse association between serum total cholesterol and cancer mortality in Dutch civil servants. AmJ Epidemiol 1993;137:966-976.
25. Iso H, Naito Y, Kitamura A, Sato S, Kiyama M, Takayama Y, Iida M, Shimamoto T, Sankai T, Komachi Y. Serum total cholesterol and mortality in a Japanese population. J Clin Epidemiol 1994;47:961-969.
26. Iribarren C, Reed DM, Burchfiel CM, Dwyer JH. Serum total cholesterol and mortality: confounding factors and risk modification in Japanese-American men. JAMA 1995;273:1926-1932.
27. Wannamethee G, Shaper AG, Whincup PH, Walker M. Low serum cholesterol concentrations and mortality in middle aged British men. BMJ 1995;311:409-413.
28. Yaari S, Goldbourt U, Even-Zohar S, Neufeld HN. Associations of serum high density lipoptotein and total cholesterol with total, cardiovascular, and cancer mortality in a 7-year prospective study of 10,000 men. Lancet 1981;1:1011-1015.
29. Dyer AR, Stamler J, Paul O, Shekelle RB, Schoenberger JA, Berkson DM, Lepper M, Collette P, Shekelle S, Lindberg HA. Serum cholesterol and risk of death from cancer and other causes in three Chicago epidemiological studies. J Chron Dis 1981;34:249-260.
30. Salonen JT. Risk of cancer and death in relation to serum cholesterol: a longitudinal study in an eastern Finnish population with high overall cholesterol level. Am J Epidemiol 1982;116:622-630.
31. Wingard DL, Criqui MH, Holdbook MJ, Barrett-Connor E. Plasma cholesterol and cancer morbidity and mortality in an adult community. J Chron Dis 1984;37:401-406.
32. Farchi G, Menotti A, Conti S. Coronary disease and survival probability from coronary and other causes of death. Am J Epidemiol 1987;126:400-408.
33. Kromhout D, Bosschieter EB, Drijver M, Coulander CL. Serum cholesterol and 25-year incidence of and mortality from myocardial infarction and cancer: the Zutphen Study. Arch Intern Med 1988;148:1051-1055.
34. Shaper AG, Philips AN, Pocock S J. Plasma cholesterol, coronary heart disease and cancer. BMJ 1989;298:1381.
35. Baptiste S, Nasca PC, Doyle JT, Rothenberg RR, MacCubbin PA, Mettlin C, Metzger BB, Carlton KA. Cholesterol and cancer in a population of male civil service workers. Int J Epidemiol 1992;21:16-21.
36. Davey Smith G, Shipley MJ, Marmot MG, Rose G. Plasma cholesterol concentration and mortality: the Whitehall Study. JAMA 1992;267:70-76.
37. Kritchevsky SB, Wilcosky TC, Morris DL, Truong KN, Tyroler HA. Changes in plasma lipid and lipoprotein cholesterol and weight prior to the diagnosis of cancer. Cancer Res 1991;51:3198-3203.
38. Pekkanen J, Nissinen A, Vartiainen E, Salonen JT, Punsar S, Karvonen MJ. Changes in serum cholesterol level and mortality: a 30-year follow-up: the Finnish cohorts of the Seven Countries Study. Am J Epidemiol 1994;139: 155-165.
39. Iribarren C, Reed DM, Chen R, Yano K, Dwyer JH. Low serum cholesterol and mortality: which is the cause and which is the effect? Circulation 1995;92:2396-2403.
40. Etienne G, Papin JP, Renault H. Une méthode simple de dosage du cholestérol total par voie automatique. Ann Biol Clin 1963;21:851-854.
41. Kessler G, Lederer H. Fluorometric measurement of triglycerides. In: Comm. Symposium Technicon: Automation in Analytical Chemistry. New York: Technicon, 1965.
42. Claude JR, Corre F. Considérations pratiques sur le dosage semi-automatique des triglycerides sériques par fluorométrie (méthode de Kessler et Lederer): comparaison avec la méthode manuelle colorimétrique de Van Handel et Zilversmit. Ann Biol Clin 1968;26:451-455.
43. World Health Organization. International Classification of Diseases. 8th revision. Geneva: World Health Organization, 1967.
44. World Health Organization. International Classification of Diseases. 9th revision. Geneva: World Health Organization, 1977.
45. Hershcopf RJ, Elahi D, Andres R, Baldwin HL, Raizes GS, Schocken DD, Tobin JD. Longitudinal changes in semm cholesterol in man: an epidemiologic search for an etiology. J Chron Dis 1982;35:101-114.
46. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet 1994;344:1719-1723.
47. Richard JL, Cambien F, Ducimetière P. Particularité épidémiologique de la maladie coronarienne en France. Presse Méd 1981;10:1111-1114.
48. Buck C, Donner A. Cancer incidence in hypertensives. Cancer 1987;59: 1386-1390.
49. Goldbourt U, Holtzman R, Yaari S, Cohen L, Katz L, Neufeld HN. Elevated systolic blood pressure as a predictor of longterm cancer mortality. J Natl Cancer Inst 1986;77:63-70.
50. Wannamethee G, Shaper AG. Blood pressure and cancer in middle-aged British men. Int J Epidemiol 1996;25:22-31.
51. Grove JS, Nomura A, Severson RK, Stemmermann GN. The association of blood pressure with cancer incidence in a prospective study. Am J Epidemiol 1991;134:942-947.
52. Clausen J, Jensen G. Blood pressure and mortality: an epidemiological survey with 10 years follow-up. J Hum Hypertens 1992;6:53-59.
53. Hiatt RA, Fierman BH. Serum cholesterol and the incidence of cancer in a large cohort. J Chron Dis 1986;39:861-870.
54. Law MR, Thompson SG. Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies. Cancer Causes Control 1991; 2:253-261.
55. Spielberg RJ, Schaeffer EJ, Margrath IT, Edwards BK. Plasma lipid alterations in leukemia and lymphoma. Am J Med 1982;72:775-782.
56. Venkatanarayanan S, Nagarajan B. Association between tumour status and serum lipoprotein cholesterol in hemopoietic malignancy. Biochem Int 1988;17:499-507.
57. Budd D, Ginsberg H. Hypocholesterolemia and acute myelogenous leukemia: association between disease activity and plasma low-density lipoprotein cholesterol concentrations. Cancer 1986;58:1361-1365.
58. Jacobs D, Blackburn H, Higgins M, Reed D, Iso H, McMillan G, Neaton J, Nelson J, Potter J, Rifkind B, Rossouw J, Shekelle R, Yusuf S. Report of the conference on low blood cholesterol: mortality associations. Circulation 1992;86:1046-1060.
59. Wallace RB, Rost C, Burmeister LF, Pomrehn PR. Cancer incidence in humans: relationship to plasma lipids and relative weight. J Natl Cancer Inst 1982;68:915-918.
60. Chick J, Kreitman J, Plant M. Mean cell volume and gamma-glutamyl-transpeptidase as markers of drinking in working men. Lancet 1981;1:1249-1251.
61. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990;301:309-314.
62. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4 S). Lancet 1994;344:1383-1389.
63. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-1307.
64. Kritchevsky SB. Dietary lipids and the low blood cholesterol-cancer association. Am J Epidemiol 1992;135:509-520.
65. Zureik M, Ducimetière P, Warnet J-M, Orssaud G. Fatty acid proportions in cholesterol esters and risk of premature death from cancer in middle aged French men. BMJ 1995;311:1251-1254.
66. Hennekens CH, Buring JE, Manson JAE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasm and cardiovascular disease. N Engl J Med 1996;334: 1345-1149.
67. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S, Hammar S. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-1155.